Jushi Holdings (JUSHF) Operating Income (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Operating Income came in at $1.6 million in Q1 2026, up 184.61% year-on-year from $556205.3 in Q1 2025, and up 102.43% on a QoQ basis from $782000.0 in Q4 2025.
Jushi Holdings (JUSHF) Operating Income (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Operating Income data on file, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Operating Income rose 184.61% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 70.43% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, down 55.34% from the prior year.
- Operating Income for Q1 2026 stood at $1.6 million, up from $782000.0 in the prior quarter.
- Over the last five years, Operating Income for JUSHF reached as high as $8.4 million in Q2 2024 and fell as low as -$139.2 million in Q4 2022.
- Historically, Operating Income has averaged -$12.1 million across 5 years, with a median of $180000.0 in 2024.
- Across the five-year window, Operating Income sank 2667.31% in 2022 and jumped 1198.89% in 2025, its largest moves.
- Year by year, Operating Income stood at -$139.2 million in 2022, then jumped by 95.31% to -$6.5 million in 2023, then soared by 71.84% to -$1.8 million in 2024, then soared by 142.5% to $782000.0 in 2025, then jumped by 102.43% to $1.6 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were $1.6 million in Q1 2026, $782000.0 in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Jushi Holdings | 79.96 Mn | 40.26 Mn | 29.88 Mn | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 782,000.00 |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | 180,000.00 |
| Jun 30, 2024 | 8.40 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | -6.53 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | -2.51 Mn |
| Dec 31, 2022 | -139.21 Mn |
| Sep 30, 2022 | -50.45 Mn |
| Jun 30, 2022 | -12.08 Mn |
| Mar 31, 2022 | -18.20 Mn |
| Dec 31, 2021 | -26.03 Mn |
| Sep 30, 2021 | -1.82 Mn |
| Jun 30, 2021 | -4.74 Mn |